[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised

CEO Severin Schwan on the results: “The demand for coronavirus tests remained high in the third quarter due to the Delta variant.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news